Turnstone Biologics Q1 EPS $(0.51) Misses $(0.26) Estimate

Benzinga · 5d ago
Turnstone Biologics (NASDAQ:TSBX) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.26) by 96.15 percent. This is a 40 percent increase over losses of $(0.85) per share from the same period last year.